Pacient s metastatickým karcinomem ledviny a idiopatickou trombocytopenickou purpurou léčený sunitinibem
| Title in English | Case report of a patient with metastatic renal cell carcinoma and idiopathic thrombocytopenic purpura treated with sunitinib |
|---|---|
| Authors | |
| Year of publication | 2014 |
| Type | Article in Periodical |
| Magazine / Source | Onkologie |
| MU Faculty or unit | |
| Citation | |
| Field | Oncology and hematology |
| Keywords | sunitinib; metastatic renal cell carcinoma; idiopathic thrombocytopenic purpura |
| Description | In a patient with metastatic renal cell carcinoma, concomitantly treated with corticoids because of idiopathic thrombocytopenic purpura (ITP), an unusually long survival of 70 months with minimal toxicity has been achieved using sunitinib. In patients with renal cell cancer toxicity of systemic therapy could be a serious and limiting factor. In this patient with serious comorbidity, therapy with sunitinib resulted in significant clinical result without any major toxicity. |